Intest (INTT) Q3 2025: Orders Surge 34% as Backlog Hits $49M, Diversification Drives Recovery Readiness
Intest’s Q3 saw a decisive inflection in order momentum, with bookings up 34% year over year and backlog swelling to $49.3 million, led by auto EV and defense aerospace demand. While revenue dipped on shipment delays and ongoing semi-market weakness, management’s tone and funnel visibility signal a company positioned for gradual recovery. Investors should focus on how Intest’s diversification and new product traction set the stage for outperformance as capital cycles thaw.
Summary
- Order Book Inflection: Bookings rebounded sharply, led by auto EV and defense aerospace customers.
- Operational Hurdles Offset by Product Wins: Shipment delays were tied to new tech launches, not demand shortfall.
- Backlog Visibility Expands: Substantial backlog and healthy funnel support a gradual recovery thesis.
Performance Analysis
Intest’s Q3 2025 results highlight the tension between near-term execution headwinds and longer-term demand recovery. Revenue of $26.2 million fell short of guidance, impacted by $2 million in delayed shipments, primarily in life sciences and semi markets. These delays were not demand-driven, but rather stemmed from technical challenges associated with new customer projects and product capabilities, which have since been resolved and shipped. Gross margin compressed to 41.9%, reflecting lower volumes and unfavorable mix, though ongoing tariff mitigation efforts partially offset the impact.
Year-over-year, revenue declined by $4 million, with semi, auto EV, and defense aerospace all softer, only partially offset by gains in life sciences and safety/security. However, the key signal is in orders: total bookings surged 34.2% year over year, led by a doubling in auto EV orders to $14.6 million and a more than twofold increase in defense aerospace to $6.4 million. The resulting backlog of $49.3 million is the highest since Q2 2022, with over half scheduled to ship in 2026, providing multi-quarter visibility.
- Order Surge Driven by Diversification: Auto EV and defense aerospace accounted for the bulk of sequential order growth, validating the company’s end-market expansion strategy.
- Cost Controls Cushion Margin Pressure: Operating expenses declined both sequentially and year over year, aided by facility consolidation and ongoing cost reduction actions.
- Cash Generation Remains Solid: Debt reduction and a $1.8 million increase in cash underscore Intest’s ability to self-fund growth initiatives through the cycle.
The quarter’s financial picture is one of short-term softness offset by structural progress in customer diversification and a growing backlog that positions Intest for a gradual, rather than abrupt, recovery.
Executive Commentary
"After several months of order sluggishness as tariff and economic uncertainties complicated customers' capital investment plans, it's refreshing to see some pockets of customers break free and move forward with capital projects... Most of this improving demand is coming from customers in the automotive and defense aerospace end markets, a clear testament to the success of our market diversification strategy."
Nick Grant, President and CEO
"We are forecasting gross margin of approximately 43% and operating expenses of 12.3 to 12.7 million, excluding approximately 200,000 of restructuring expenses... Intest remains a cash-generating company that we believe has the financial resources to scale the business and achieve our Vision 2030 goals."
Duncan Gilmore, Chief Financial Officer and Treasurer
Strategic Positioning
1. End-Market Diversification Yields Results
Intest’s push into auto EV, defense aerospace, and life sciences is delivering tangible results, with these segments driving the bulk of order growth and backlog expansion. Auto EV demand is fueled by Tier 1 electronics suppliers preparing for 2027 model launches, while defense aerospace orders reflect increased testing needs for next-generation weapons systems. This diversification reduces reliance on the volatile semi market and provides a buffer against sector-specific downturns.
2. Innovation and New Product Adoption
Technical challenges in Q3 were the byproduct of launching new capabilities and entering new customer verticals, not execution failures. For example, AccuLogic’s expanded flying probe solutions, now including radio frequency and oscilloscope measurement, secured multiple system orders from new customers. These technology investments are building an installed base and positioning Intest for future cross-sell opportunities as recovery takes hold.
3. Margin Management and Cost Structure Discipline
Gross margin pressure was partially offset by proactive cost controls, including a facility consolidation in the Netherlands that will yield $500,000 in annual savings from 2026. Operating expenses trended lower, and management continues to execute tariff mitigation tactics to shield profitability. This discipline ensures Intest can weather near-term volume fluctuations without sacrificing long-term strategic investments.
4. Backlog and Funnel Signal Recovery Trajectory
With backlog at $49.3 million and a strong pipeline, over half of which is scheduled to ship in 2026, Intest has multi-quarter demand visibility. Management emphasized that while many customers remain cautious, especially in semi, the company’s opportunity funnel remains elevated, suggesting a gradual, not abrupt, market recovery.
5. Vision 2030 Remains the North Star
All strategic moves are tied to the Vision 2030 plan, which focuses on scaling through innovation, customer diversification, and operational efficiency. The Q3 order surge provides early validation, but management remains clear-eyed about the need for continued execution and disciplined capital allocation as the recovery unfolds.
Key Considerations
This quarter marks a strategic inflection for Intest, as the company’s diversification strategy and new technology investments shift from theory to tangible order growth and backlog expansion. The following considerations are central to understanding the company’s evolving risk-reward profile:
Key Considerations:
- Order Book Strength: Bookings in auto EV and defense aerospace are leading indicators of future revenue and margin mix improvement.
- Execution on Product Innovation: Technical shipment delays were resolved, and customer satisfaction remained high, but ongoing new product launches will require continued operational rigor.
- End-Market Recovery Pace: Semi remains soft, with both front-end and back-end customers hesitant due to tariffs and capital allocation uncertainty.
- Cost Management Leverage: Facility consolidation and expense discipline provide margin support as volumes recover.
- Visibility and Guidance Approach: Management’s decision to guide only one quarter ahead reflects both caution and discipline amid macro uncertainty.
Risks
Intest’s recovery is not without risk. Prolonged semi-market sluggishness, further delays in capital spending by industrial and life sciences customers, or new technical hurdles in product launches could dampen the pace of revenue growth. Tariff volatility and supply chain disruptions remain ongoing challenges, and the company’s guidance conservatism signals limited visibility into the timing and breadth of a full market recovery.
Forward Outlook
For Q4 2025, Intest guided to:
- Revenue of $30 million to $32 million
- Gross margin of approximately 43%
- Operating expenses of $12.3 million to $12.7 million, excluding restructuring
For full-year 2025, management maintained a quarter-by-quarter guidance approach, citing:
- Uncertainty in timing of broad market recovery, especially in semi
- Confidence in backlog fulfillment and shipment of delayed Q3 orders in Q4
Management highlighted that over half the current backlog is scheduled for 2026 shipment, providing a runway for sustained recovery as customer capital spending resumes.
Takeaways
Intest’s Q3 demonstrates that its market diversification and innovation strategy is yielding results, even as revenue faces near-term headwinds. The company’s strong order book, disciplined cost management, and growing backlog underpin a gradual recovery thesis, with Vision 2030 providing a clear framework for execution.
- Order Momentum Validates Strategy: Bookings growth and backlog expansion in auto EV and defense aerospace confirm the payoff from diversification and new product investment.
- Operational Discipline Offsets Near-Term Challenges: Cost controls and cash generation provide resilience as revenue recovers and volumes scale.
- Watch for Pace of Semi Recovery: Investors should monitor semi order trends and backlog conversion as leading indicators of margin and revenue inflection in 2026.
Conclusion
Intest’s Q3 marks a turning point, with order strength and backlog visibility outweighing near-term revenue softness. As capital cycles in core end markets begin to thaw, the company’s strategic positioning and operational discipline set the stage for a multi-year growth runway.
Industry Read-Through
Intest’s results offer a clear read-through for test and measurement peers: End-market diversification, particularly into auto EV and defense aerospace, is proving critical to offsetting semi-market cyclicality. The cautious recovery in semi, especially in analog mixed signal and silicon carbide, mirrors broader industry commentary about delayed capital investment and tariff-driven uncertainty. Companies with strong pipelines, innovative product portfolios, and disciplined cost structures will be best positioned to capitalize as the cycle turns. The gradual, rather than V-shaped, recovery trajectory signaled here is likely to play out across the sector.